Sort
15,842 grants matching “pancreatic cancer”
Breaking down tumor immune privilege through targeted hypoxia reduction
$472,058Michael A. Curran · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Breaking down tumor immune privilege through targeted hypoxia reduction
$472,058Michael A. Curran · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model
$472,052David Charles Lyden · Weill Medical Coll Of Cornell Univ · R01 · FY2017 · CA
Assembly and function of outer membrane tubules in Fusobacterium nucleatum
$471,710Hung Ton-That · University Of California Los Angeles · R01 · FY2025 · DE
Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers
$471,675Stuart Duncan Ibsen · Oregon Health & Science University · R37 · FY2022 · CA
Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers
$471,675Stuart Duncan Ibsen · Oregon Health & Science University · R37 · FY2025 · CA
Project 3: Transcriptomic subtypes, response predictions, and therapy selection
$471,647Jen Jen Yeh · Univ Of North Carolina Chapel Hill · P50 · FY2022 · CA
Roles of NADPH Oxidase 5 and Dual Oxidase 2 in Cancer
$471,626James Doroshow · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Theranostic Nano particles for Targeted Treatment of Pancreatic Cancer
$471,517Lily Yang · Emory University · U01 · FY2010 · CA
Function of IL35+ B cells in pancreatic cancer
$471,387Yuliya Pylayeva-Gupta · Univ Of North Carolina Chapel Hill · R37 · FY2020 · CA
Conformational Regulation and Therapeutic Targeting of Oncogenic KRAS
$471,255John R Engen · Northeastern University · R01 · FY2022 · CA
Conformational Regulation and Therapeutic Targeting of Oncogenic KRAS
$471,255Thomas Edward Wales · Northeastern University · R01 · FY2023 · CA
Promotion of pancreatic cancer by perfluorooctanoic acid
$471,248Barbara A Hocevar · Trustees Of Indiana University · R15 · FY2016 · ES
Theranostic Nano particles for Targeted Treatment of Pancreatic Cancer
$471,193Lily Yang · Emory University · U01 · FY2013 · CA
MULTIPLEX CHEMICAL TAGS FOR HIGH-THROUGHPUT GLYCAN AND GLYCOPEPTIDE QUANTITATION AND CHARACTERIZATION
$470,945Lingjun Li · University Of Wisconsin-Madison · U01 · FY2018 · CA
Histone chaperones and cell state regulation
$470,931Amanda Rietta Wasylishen · University Of Cincinnati · R56 · FY2023 · DK
MOUSE MODELS FOR HUMAN CANCER
$470,873University Of Wisconsin Madison · U01 · FY2000 · CA
Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia
$470,819Oleh Taratula · Oregon State University · R37 · FY2019 · CA
Project 2: Exploiting Labile Iron Pools for Improving NSCLC Therapy Using Pharmacological Ascorbate
$470,783Douglas Robert Spitz · University Of Iowa · P01 · FY2022 · CA
Myofibroblasts in Gastrointestinal Cancers
$470,654Timothy Cragin Wang · Columbia University Health Sciences · U54 · FY2013 · CA
Functions of the LKB1 tumor suppressor in control in metabolism and epigenetics
$470,621Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2022 · CA
Magnetoresistive Sensor Platform for Parallel Cancer Marker Detection
$470,407Marc D Porter · University Of Utah · U01 · FY2010 · CA
(PQD3)Molecular Profiles associated with Long-Term Survival in pancreas Cancer
$470,355Nita Ahuja · Johns Hopkins University · R01 · FY2016 · CA
MECHANISMS OF SIGNAL TRANSDUCTION BY RAS PROTEINS
$470,319Dafna Bar-Sagi · New York University School Of Medicine · R37 · FY2008 · CA
ROS-targeted therapy for pancreatic cancer
$470,257Nouri Neamati · University Of Michigan At Ann Arbor · R01 · FY2019 · CA